^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CAR.B7-H3 T
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
UNC Lineberger Comprehensive Cancer Center
Drug class:
B7-H3-targeted CAR-T immunotherapy
Related drugs:
